Malignant prolactinoma – can a long-term survival be affected?
																	
									Authors:
											K. Menclová						1; 											T. Novák						2; 											D. Netuka						3; 											M. Kosák						4; 											Radek Pohnán						1							
								
							
																
				
									Authors‘ workplace:
											Chirurgická klinika 2. LF UK a ÚVN, Praha
						1; 											Onkologická klinika 2. LF UK a FN Motol, Praha
						2; 											Neurochirurgická a neuroonkologická, klinika 1. LF UK a ÚVN, Praha
						3; 											Interní klinika 1. LF UK a ÚVN, Praha
						4										
				
									Published in:
					Cesk Slov Neurol N 2021; 84/117(3): 274-276
					
				
									Category:
					Letters to Editor
					
				
									doi:
					
						https://doi.org/10.48095/cccsnn2021274
					
							
Sources
1. Moscote-Salazar LR, Satyarthee GD, Calderon-Miranda WG. Prolactin secreting pituitary carcinoma with extracranial spread presenting with pathological fracture of femur. J Neurosci Rural Pract 2018; 9(1): 170–173. doi: 10.4103/ jnrp.jnrp_325_17.
2. Chen C, Yin S, Zhang S. Treatment of aggressive prolactinoma with temozolomide: a case report and review of literature up to date. Medicine (Baltimore) 2017; 96(47): e8733. doi: 10.1097/ MD.0000000000008733.
3. Hong AR, Yoon JH, Kim HK. Malignant prolactinoma with liver metastases masquerading as metastatic gastrointestinal stromal tumor: a case report and literature review. Front Endocrinol (Lausanne) 2020; 11 : 451. doi: 10.3389/ fendo.2020.00451.
4. Kars M, Roelfsema F, Pereira AM. Malignant prolactinoma: case report and review of the literature. EJE 2006; 155 : 523–534. doi: 10.1530/ eje.1.02268.
5. Di Ieva A, Rotondo F, Syro L. Aggressive pituitary adenomas – diagnosis and emerging treatments. Nat Rev Endocrinol 2014; 10 : 423–435. doi: 10.1038/ nrendo.2014.64.
6. Dworakowska D, Grossman AB. Aggressive and malignant pituitary tumours: state-of-the-art. Endocrine-Related Cancer 2018; 25(11): R559–R575. doi: 10.1530/ ERC - 18-0228.
7. Xu L, Khaddour K, Chen J. Pituitary carcinoma: two case reports and review of literature. World J Clin Oncol 2020; 11(2): 91–102. doi: 10.5306/ wjco.v11.i2.91.
8. Oscar DB, Lea JA, Silvia BC. Temozolomide therapy for aggressive pituitary tumors: results in a small series of patients from Argentina. Int J Endocrinol 2015; 2015 : 587893. doi: 10.1155/ 2015/ 587893.
9. Pernicone PJ, Scheithauer BW, Sebo TJ. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 1997; 79(4): 804–812. doi: 10.1002/ (SICI)1097-0142(19970 215)79 : 4<804:: AID-CNCR18>3.0.CO;2-3.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
					2021 Issue 3
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
 - Memantine Eases Daily Life for Patients and Caregivers
 - Memantine in Dementia Therapy – Current Findings and Possible Future Applications
 - Metamizole vs. Tramadol in Postoperative Analgesia
 - Deep stimulation of the globus pallidus improved clinical symptoms in a patient with refractory parkinsonism and genetic mutation
 
Most read in this issue
- Developmental dysphasia – functional and structural correlations
 - Guidelines on intravenous thrombolysis in the treatment of acute cerebral infarction – 2021 version
 - Ethylenglycol poisoning
 - Surgical treatment possibilities of drug-resistant Ménière‘s disease